VEGFA and endometriosis: VEGF-A demonstrated higher sensitivity (93.3%), specificity (96.7%), and accuracy (95.0%) in distinguishing endometriosis patients from controls compared to Ca-125, which showed a sensitivity of 70.0%, specificity of 90.0%, and accuracy of 85.0%.